List view / Grid view
29 July 2015 | By Victoria White
Scientists have precisely modifed human T cells using the CRISPR genome-editing system- a breakthrough that could lead to CRISPR/Cas9-based therapies...
28 July 2015 | By Victoria White
Scientists have developed a molecule, called 'compound 14', that acts as an exercise mimic, which could potentially help treat type 2 diabetes and obesity...
22 July 2015 | By Victoria White
KalVista Pharmaceuticals has raised $33 million in Series B financing to support its research and clinical development programmes...
20 July 2015 | By
Using existing drugs to restore basic biological processes in human cells, researchers may have devised effective treatments for mitochondrial diseases...
20 July 2015 | By Victoria White
Certain patients with type 2 diabetes may have specific genetic risk factors that put them at higher risk for developing Alzheimer’s disease...
1 July 2015 | By Victoria White
A European Nano-Characterisation Laboratory has launched with the aim of reaching a level of international excellence in nanomedicine characterisation...
23 June 2015 | By Victoria White
Researchers have created the first smart insulin patch that can detect increases in blood sugar levels and secrete doses of insulin into the bloodstream...
18 June 2015 | By Victoria White
A new drug screening technology developed at the Harvard T.H. Chan School of Public Health has identified a new potential anti-diabetes compound - azoramide...
17 June 2015 | By Victoria White
AstraZeneca is to collaborate with Inserm to investigate new therapeutic approaches to type 2 diabetes and Chronic Kidney Disease (CKD)...
16 June 2015 | By Victoria White
Researchers have found that a hormone called urocortin 3 is released at the same time as insulin and acts to damp down insulin production...
12 June 2015 | By Victoria White
Researchers combined a variety of structural biology approaches to rationally design a new compound that could repress the biological activity of PPARy...
2 June 2015 | By Victoria White
Astellas Pharma and Anokion are to collaborate in the fields of type 1 diabetes and coeliac disease by establishing new drug discovery company Kanyos Bio...
28 May 2015 | By Victoria White
TSRI scientists have been awarded nearly $2.2 million to advance understanding of IP6K1 and develop innovative approaches for the treatment of obesity...
20 May 2015 | By Victoria White
Zealand has advanced a multiple-dose version of ZP4207 into clinical development for the treatment of mild to moderate hypoglycaemia in diabetes patients...
29 April 2015 | By Victoria White
An international team of scientists has identified a new genetic mutation that appears to protect people from developing Type 2 diabetes...
